Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy

Fred Poordad, Michael Bennett, Thomas E. Sepe, Eric Cohen, Robert W. Reindollar, Gregory Everson, Raymond W. Phillips, Asma Siddique, J. Greg Sullivan, Tami Pilot-Matias, Manal Abunimeh, Daniel E. Cohen, Ziad Younes

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences